Laporan Laba Rugi (TTM)
Laporan Laba Rugi Can-Fite BioPharma Ltd. - Depositary Receipt (Common Stock) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Change (%) | -5.22 | -6.55 | 6.45 | 5.27 | 6.76 | 6.68 | -5.05 | -5.44 | -0.86 | -1.11 | -1.00 | -1.01 | -5.35 | -5.11 | -5.39 | -2.55 | 3.69 | -8.46 | -9.24 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | ||||||||||||||||||||
| Change (%) | ||||||||||||||||||||
| % of Revenue | ||||||||||||||||||||
| Gross Operating Profit | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Change (%) | -5.22 | -6.55 | 6.45 | 5.27 | 6.76 | 6.68 | -5.05 | -5.44 | -0.86 | -1.11 | -1.00 | -1.01 | -5.35 | -5.11 | -5.39 | -2.55 | 3.69 | -8.46 | -9.24 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| SG&A | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 |
| Change (%) | -2.74 | 10.61 | 3.80 | 3.93 | 9.20 | -6.81 | -1.51 | -2.30 | -8.85 | 2.96 | -6.12 | 0.69 | -3.40 | -2.86 | 4.82 | -0.03 | 1.30 | 8.88 | 8.15 | |
| % of Revenue | 376.89 | 386.76 | 457.78 | 446.38 | 440.68 | 450.76 | 393.74 | 408.45 | 422.03 | 388.02 | 404.00 | 383.10 | 389.68 | 397.71 | 407.16 | 451.12 | 462.77 | 452.08 | 537.68 | 640.71 |
| R&D | 13 | 12 | 9 | 9 | 10 | 10 | 10 | 9 | 8 | 8 | 8 | 8 | 7 | 6 | 5 | 5 | 6 | 6 | 6 | 6 |
| Change (%) | -7.81 | -20.65 | -8.18 | 10.77 | 2.13 | 5.26 | -10.18 | -9.70 | -7.69 | 3.09 | -1.20 | -9.32 | -16.56 | -10.34 | 1.61 | 2.51 | 3.02 | 1.29 | 1.28 | |
| % of Revenue | 1,610.43 | 1,566.32 | 1,330.01 | 1,147.17 | 1,207.13 | 1,154.75 | 1,139.34 | 1,077.89 | 1,029.38 | 958.40 | 999.13 | 997.10 | 913.38 | 805.25 | 760.92 | 817.24 | 859.69 | 854.15 | 945.14 | 1,054.64 |
| OpEx | 16 | 15 | 13 | 12 | 13 | 14 | 14 | 13 | 12 | 11 | 11 | 11 | 10 | 9 | 8 | 8 | 9 | 9 | 9 | 9 |
| Change (%) | -6.85 | -14.46 | -5.11 | 8.85 | 4.02 | 1.87 | -7.95 | -7.66 | -8.03 | 3.05 | -2.62 | -6.54 | -12.62 | -7.87 | 2.73 | 1.61 | 2.42 | 3.92 | 3.77 | |
| % of Revenue | 1,987.33 | 1,953.08 | 1,787.80 | 1,593.54 | 1,647.81 | 1,605.51 | 1,533.08 | 1,486.34 | 1,451.41 | 1,346.42 | 1,403.12 | 1,380.20 | 1,303.06 | 1,202.96 | 1,168.09 | 1,268.37 | 1,322.46 | 1,306.23 | 1,482.82 | 1,695.36 |
| Operating Income | -15 | -14 | -12 | -11 | -12 | -13 | -13 | -12 | -11 | -10 | -10 | -10 | -9 | -8 | -8 | -8 | -8 | -8 | -9 | -9 |
| Change (%) | -6.94 | -14.89 | -5.80 | 9.09 | 3.84 | 1.55 | -8.15 | -7.82 | -8.56 | 3.39 | -2.74 | -6.97 | -13.23 | -8.11 | 3.49 | 1.96 | 2.32 | 4.94 | 4.71 | |
| % of Revenue | -1,887.33 | -1,853.08 | -1,687.80 | -1,493.54 | -1,547.81 | -1,505.51 | -1,433.08 | -1,386.34 | -1,351.41 | -1,246.42 | -1,303.12 | -1,280.20 | -1,203.06 | -1,102.96 | -1,068.09 | -1,168.37 | -1,222.46 | -1,206.23 | -1,382.82 | -1,595.36 |
| Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||||||||
| Change (%) | 69.63 | -18.18 | -25.59 | -37.10 | -48.37 | 151.72 | ||||||||||||||
| % of Revenue | -26.58 | -47.58 | -41.65 | -29.12 | -17.40 | -37.03 | -20.14 | -53.61 | ||||||||||||
| Net Income | -13 | -14 | -12 | -11 | -12 | -13 | -13 | -12 | -11 | -10 | -10 | -10 | -9 | -8 | -7 | -7 | -8 | -8 | -8 | -9 |
| Change (%) | 15.03 | -17.06 | -5.63 | 7.30 | 4.00 | 4.41 | -7.81 | -7.17 | -9.75 | 1.14 | -5.06 | -7.85 | -15.19 | -7.49 | 4.37 | 2.71 | 4.09 | 5.83 | 5.51 | |
| % of Revenue | -1,559.75 | -1,892.92 | -1,680.08 | -1,489.46 | -1,518.15 | -1,478.90 | -1,447.36 | -1,405.44 | -1,379.68 | -1,255.93 | -1,284.52 | -1,231.78 | -1,146.62 | -1,027.46 | -1,001.77 | -1,105.10 | -1,164.69 | -1,169.14 | -1,351.62 | -1,571.25 |
Source: Capital IQ
